PEG-rhG-CSF in Lymphoma Patients After Autologous Hematopoietic Stem Cell Transplantation
Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of the study is to evaluate the efficacy and safety of PEG-rhG-CSF on the
recovery of hematopoietic function after autologous stem cell transplantation in patients
with lymphoma.